Citius Oncology, Inc. (CTOR) — Financial Flexibility Index
Latest as of March 2026:
-0.06x
Citius Oncology, Inc. (CTOR) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $5.00) represents 0% of total liabilities ($65.43 Million).
Financial Flexibility Index
-0.06x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-3.97 Million
Operating CF − Capex
Total Liabilities
$65.43 Million
USD
Capital Expenditures
$5.00
USD
Citius Oncology, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Citius Oncology, Inc. across 4 annual periods. See how liquid is Citius Oncology, Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Citius Oncology, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Citius Oncology, Inc.. For the full company profile including market capitalisation, see CTOR stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-5.49 Million | $-5.49 Million | $56.08 Million | ▼ -3063.1% |
| 2024 | 0.00x | $126.36K | $126.35K | $38.23 Million | ▲ +112.2% |
| 2023 | -0.03x | $-601.30K | $-601.30K | $22.20 Million | ▼ -262.7% |
| 2022 | -0.01x | $-47.97K | $-47.97K | $6.42 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities